These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27786243)

  • 1. New strategies for the treatment and prevention of primary headache disorders.
    Schuster NM; Rapoport AM
    Nat Rev Neurol; 2016 Oct; 12(11):635-650. PubMed ID: 27786243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategies that act on the peripheral nervous system in primary headache disorders.
    Tajti J; Szok D; Nyári A; Vécsei L
    Expert Rev Neurother; 2019 Jun; 19(6):509-533. PubMed ID: 31053055
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging treatments for the primary headache disorders.
    Schuster NM; Vollbracht S; Rapoport AM
    Neurol Sci; 2015 May; 36 Suppl 1():109-13. PubMed ID: 26017524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Treatments in Episodic Migraine.
    Grimsrud KW; Halker Singh RB
    Curr Pain Headache Rep; 2018 Jul; 22(9):61. PubMed ID: 30014208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive neuromodulation in migraine and cluster headache.
    Starling A
    Curr Opin Neurol; 2018 Jun; 31(3):268-273. PubMed ID: 29601305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive Treatment for Episodic Migraine.
    Parikh SK; Silberstein SD
    Neurol Clin; 2019 Nov; 37(4):753-770. PubMed ID: 31563231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Neuromodulation in Migraine.
    Blech B; Starling AJ
    Curr Pain Headache Rep; 2020 Dec; 24(12):78. PubMed ID: 33326063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromodulation for the treatment of primary headache syndromes.
    Hoffmann J; May A
    Expert Rev Neurother; 2019 Mar; 19(3):261-268. PubMed ID: 30793630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
    Pellesi L; Guerzoni S; Pini LA
    Clin Pharmacol Drug Dev; 2017 Nov; 6(6):534-547. PubMed ID: 28409893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new era in headache treatment.
    Vikelis M; Spingos KC; Rapoport AM
    Neurol Sci; 2018 Jun; 39(Suppl 1):47-58. PubMed ID: 29904827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving options for the treatment of cluster headache.
    Villar-Martinez MD; Chan C; Goadsby PJ
    Curr Opin Neurol; 2020 Jun; 33(3):323-328. PubMed ID: 32209808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic approaches for the prevention and treatment of migraine.
    Diener HC; Charles A; Goadsby PJ; Holle D
    Lancet Neurol; 2015 Oct; 14(10):1010-22. PubMed ID: 26376968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic antibodies against CGRP or its receptor.
    Bigal ME; Walter S; Rapoport AM
    Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous electrical nerve stimulation (PENS) therapy for refractory primary headache disorders: a pilot study.
    Weatherall MW; Nandi D
    Br J Neurosurg; 2019 Dec; 33(6):608-612. PubMed ID: 31578882
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study.
    Dodick DW; Silberstein SD; Reed KL; Deer TR; Slavin KV; Huh B; Sharan AD; Narouze S; Mogilner AY; Trentman TL; Ordia J; Vaisman J; Goldstein J; Mekhail N
    Cephalalgia; 2015 Apr; 35(4):344-58. PubMed ID: 25078718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.
    Ashina H; Newman L; Ashina S
    Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurostimulation for primary headache disorders: Part 2, review of central neurostimulators for primary headache, overall therapeutic efficacy, safety, cost, patient selection, and future research in headache neuromodulation.
    Jenkins B; Tepper SJ
    Headache; 2011 Oct; 51(9):1408-18. PubMed ID: 21812772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine and cluster headache - the common link.
    Vollesen AL; Benemei S; Cortese F; Labastida-Ramírez A; Marchese F; Pellesi L; Romoli M; Ashina M; Lampl C;
    J Headache Pain; 2018 Sep; 19(1):89. PubMed ID: 30242519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatments for headache.
    Maasumi K; Tepper SJ; Rapoport AM
    Neurol Sci; 2017 May; 38(Suppl 1):145-156. PubMed ID: 28527051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.
    Szperka CL; VanderPluym J; Orr SL; Oakley CB; Qubty W; Patniyot I; Lagman-Bartolome AM; Morris C; Gautreaux J; Victorio MC; Hagler S; Narula S; Candee MS; Cleves-Bayon C; Rao R; Fryer RH; Bicknese AR; Yonker M; Hershey AD; Powers SW; Goadsby PJ; Gelfand AA
    Headache; 2018 Nov; 58(10):1658-1669. PubMed ID: 30324723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.